Arnado, Lorenzo, Jr. C.

HRN: 09-66-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2025
CEFTRIAXONE 1G (VIAL)
02/22/2025
03/01/2025
IV
2g
Daily
Indirect Inguinal Hernia, Right
Waiting Final Action 
06/12/2025
CEFTRIAXONE 1G (VIAL)
06/12/2025
06/18/2025
IV
2g
OD
Inguinal Hernia
Waiting Final Action 
06/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/12/2025
06/18/2025
IV
500mg
Q8
Inguinal Hernia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: